59th World Health Organisation A59/9.— Sickle-cell anaemia. 24 April 2006.
Manwani D, Frenette PS.— Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. Blood, 2013, 122, 3892-3898.
Gladwin MT.— Cardiovascular complications and risk of death in sickle-cell disease. Lancet, 2016, 387, 2565-2574.
Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. — Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. Review. JAMA, 2014, 312, 1033-1048.
Meier ER, Rampersad A.— Pediatric sickle cell disease: past successes and future challenges. Review. Pediatr Res, 2017, 81, 249-258.
Liem RI, Young LT, Thompson AA.— Prolonged QTc interval in children and young adults with sickle cell disease at steady state. Pediatr Blood Cancer, 2009, 52, 842-846.
Voskaridou E, Christoulas D, Terpos E.— Sickle cell disease and the heart: review of the current literature. Br J Hematol, 2012, 157, 664-673.
de Montalembert M, Maunoury C, Acar P, et al.—Myocardial ischaemia in children with sickle cell disease. Arch Dis Child, 2004, 89, 359-362.
Niss O, Quinn CT, Lane A, et al.— Cardiomyopa-thy with restrictive physiology in sickle cell disease. JACC Cardiovasc Imaging, 2016, 9, 243-252.
Wang ZJ, Fischer R, Chu Z, et al.— Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemia. Magn Reson Imaging, 2010, 28, 363-371.
Niss O, Fleck R, Makue F, et al.— Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia. Blood, 2017, 130, 205-213.
Seghaye MC, Duchateau J, Grabitz RG, et al. — Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: a clinical and experimental study. J Thorac Cardiovasc Surg, 1996, 111, 882-892.
Damy T, Bodez D, Habibi A, et al.— Haematologi-cal determinants of cardiac involvement in adults with sickle cell disease. Eur Heart J, 2016, 37, 1158-1167.
Levy PT, Machefsky A, Sanchez AA, et al.— Reference ranges of left ventricular strain measures by two-dimensional speckle-tracking echocardiogra-phy in childre: a systematic review and meta-analysis. J Am Soc Echocardiogr, 2016, 29, 209-225.
Quinn CT, Niss O, Fleck R, et al.— Temporal evolution of diffuse myocardial fibrosis in sickle cell anemia. Blood, 2017, 130, 3539.
Mendis S, Thygesen K, Kuulasmaa K, et al.—World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol, 2011, 40, 139-146.
Parent F, Bachir D, Inamo J, et al.— A hemodyna-mic study of pulmonary hypertension in sickle cell disease. N Engl J Med, 2011, 365, 44-53.
McLaughlin VV, Shah SJ, Souza R, et al.— Management of pulmonary arterial hypertension. J Am Coll Cardiol, 2015, 65, 1976-1997.
Machado RF, Hildesheim M, Mendelsohn L, et al.— NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease. Br J Haematol, 2011, 154, 512-520.
Khurmi N, Gorlin A, Misra L.— Perioperative considerations for patients with sickle cell disease: a narrative review. Can J Anaesth, 2017, 64, 860-869.
